Implantable device for administering a treatment solution and operating device for a syringe for filling the device

• US 6,730,060 B1
• Filed: 05/28/1999
• Issued: 05/04/2004
• Est. Priority Date: 05/29/1998
• Status: Expired due to Fees

• Current Assignee: Aqulinx Medical, Inc.
• Original Assignee: Fresenius Medical Care Deutschland GmbH (Fresenius SE & Co. KGaA)
• Inventors: Bernard, Rüdiger, Pieper, Walter, Steinbach, Bernd
• Primary Examiner(s): Hayes, Michael J.
• Application Number:
  US09/322,467
• Time in Patent Office: 1,803 Days
• Field of Search: 604/30, 604/93.01, 604/131, 604/132, 604/175, 604/247, 604/288-1-2, 604/500, 604/151, 604/502, 604/513, 604/236, 604/890.1, 604/891.1, 604/83-86, 128/DIG.12
• US Class Current: 604/131
• CPC Class Codes: A61M 5/14276 specially adapted for implantation

Abstract

An implantable device for administering a treatment solution has a first chamber for accommodating the active solution to be administered and a second chamber for accommodating a treatment solution bolus, each chamber having a port sealed with a septum. An infusion line leading to the infusion site is connected to the outlet of the first chamber. An inlet line branches off from the infusion line and is connected to the second chamber to accommodate the active solution bolus, and includes a flow device which releases the flow path to the infusion site only when the active solution bolus is supplied at a pressure above a predetermined minimum pressure. The occurrence of life-threatening situations due to sudden administration of a large quantity of active solution is prevented if the active solution is always supplied only at a pressure below the minimum pressure at which the flow path is released.

Claims

1. An implantable device for administering a treatment solution comprising:

a first housing body including;

a first chamber having a refilling port sealed by a first puncturable septum; and

a conveyance mechanism for conveying the solution out of the first chamber to an infusion site;

a second housing body separately spaced from the first housing body and including a second chamber having an inlet port sealed by a second puncturable septum;

a first fluid connection for connecting the first chamber to the infusion site; and

a second fluid connection for connecting the second chamber to the infusion site, the second fluid connection including a pressure control valve for preventing flow of the solution from the second chamber to the infusion site when the solution is supplied to the second chamber at a pressure below a predetermined minimum pressure, wherein the pressure control valve opens only when the solution is supplied to the second chamber at a pressure above the predetermined minimum pressure.

2. The device according to claim 1 wherein the first fluid connection includes an infusion line connected to the first chamber, the second fluid connection includes an inlet line connected to the second chamber and the infusion line, and the pressure control valve is arranged in the inlet line.

3. The device according to claim 2 wherein the pressure control valve includes a slitted disk.

4. The device according to claim 3 wherein the slitted disk includes silicone.

5. The device according to claim 1 wherein the predetermined minimum pressure is between 2 and 4 bar.

6. The device according to claim 5 wherein the predetermined minimum pressure is between 2.5 and 3.5 bar.

7. A method of administering a treatment solution comprising the steps of:

supplying a refillable first chamber having a refilling port sealed by a first puncturable septum, wherein a first housing body includes the refillable first chamber and a conveyance mechanism for conveying the solution out of the refillable first chamber to an infusion site, a first fluid connection connecting the refillable first chamber to the infusion site;

supplying a second chamber through a second puncturable septum, wherein a second housing body separately spaced from the first housing body includes the second chamber a second fluid connection connecting the second chamber to the infusion site;

supplying the solution to the infusion site via the first fluid connection; and

preventing flow of the solution from the second chamber to the infusion site when the solution is at a pressure below a predetermined minimum pressure, wherein a treatment solution bolus is supplied from the second chamber to the infusion site through the second fluid connection including a pressure control valve which opens only when the treatment solution bolus is supplied to the second chamber at a pressure above a predetermined minimum pressure.

8. The method according to claim 7 wherein the predetermined minimum pressure is between 2 and 4 bar.

9. The method according to claim 8 wherein the predetermined minimum pressure is between 2.5 and 3.5 bar.